These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 163843)

  • 1. Immunochemical heterogeneity of calcitonin in plasma.
    Deftos LJ; Roos BA; Bronzert D; Parthemore JG
    J Clin Endocrinol Metab; 1975 Mar; 40(3):409-12. PubMed ID: 163843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma.
    Sizemore GW; Hpeath H; Larson JM
    J Clin Invest; 1975 May; 55(5):1111-8. PubMed ID: 47335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion of chromogranin A by peptide-producing endocrine neoplasms.
    O'Connor DT; Deftos LJ
    N Engl J Med; 1986 May; 314(18):1145-51. PubMed ID: 3007986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of region specific radioimmunoassays for characterization of circulating calcitonin in patients with medullary carcinoma of the thyroid gland.
    Myhre L; Gautvik KM
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):449-61. PubMed ID: 474037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.
    Goltzman D; Tischler AS
    J Clin Invest; 1978 Feb; 61(2):449-58. PubMed ID: 621283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma.
    Rude RK; Matsumoto S; Singer FR
    Miner Electrolyte Metab; 1982 Jun; 7(6):292-7. PubMed ID: 6302462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer.
    Becker KL; Snider RH; Silva OL; Moore CF
    Acta Endocrinol (Copenh); 1978 Sep; 89(1):89-99. PubMed ID: 211777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-heterogeneity of the calcitonins of hypercalcemia, breast and lung cancers and medullary carcinoma of thyroid.
    Roof BS; Weinstein R; Vujic I; Burdash NM
    Biomedicine; 1979 Jun; 30(2):82-90. PubMed ID: 476268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heterogeneity of immunoreactive calcitonin in the plasma of patients with bone marrow cancer].
    Moukhtar MS; Jullienne A; Taboulet J; Calmettes C; Raulais D; Milhaud G
    Pathol Biol (Paris); 1975 Dec; 23(10):809-14. PubMed ID: 772524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical heterogeneity of calcitonin in man: effect on radioimmunoassay.
    Snider RH; Silva OL; Moor CF; Becker KL
    Clin Chim Acta; 1977 Apr; 76(1):1-14. PubMed ID: 856499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of plasma and urinary immunoreactive calcitonin in patients with medullary carcinoma of the thyroid.
    Morimoto S; Okada Y; Onishi T; Takai S; Miyauchi A; Lee S; Nishioka Y; Kumahara Y
    Endocrinol Jpn; 1981 Oct; 28(5):583-94. PubMed ID: 7344949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of immunoreactive calcitonin in extracts of normal human thyroid.
    Woloszczuk W; Kovarik J
    Horm Metab Res; 1981 Aug; 13(8):460-3. PubMed ID: 6173296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin immunoreactivity and hypercalcitoninemia in two patients with sporadic, nonfamilial, gastroenteropancreatic neuroendocrine tumors.
    McLeod MK; Vinik AI
    Surgery; 1992 May; 111(5):484-8. PubMed ID: 1350867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical heterogeneity of calcitonin in tumor, tumor venous effluent, and peripheral blood of patients with medullary thyroid carcinoma.
    Heath H; Sizemore GW
    J Lab Clin Med; 1979 Mar; 93(3):390-401. PubMed ID: 429850
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Hypersecretion of calcitonin in neoplastic conditions.
    Milhaud G; Calmette C; Taboulet J; Julienne A; Moukhtar MS
    Lancet; 1974 Mar; 1(7855):462-3. PubMed ID: 4131473
    [No Abstract]   [Full Text] [Related]  

  • 16. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
    Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S
    Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of non-commercial methods for estimation of immunoreactive serum calcitonin in clinical practice (comparison of two methods).
    Bednár J; Neradilová M; Soutorová M; Bílek R; Nĕmec J; Pechová M; Havelka J
    Czech Med; 1991; 14(4):205-12. PubMed ID: 1842705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
    Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
    Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple immunoreactive forms of calcitonin in human plasma.
    Singer FR; Habener JF
    Biochem Biophys Res Commun; 1974 Nov; 61(2):710-6. PubMed ID: 4477010
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcitonin heterogeneity: in vivo and in vitro studies.
    Roos BA; Parthemore JG; Lee JC; Deftos LJ
    Calcif Tissue Res; 1977 May; 22 Suppl():298-302. PubMed ID: 199331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.